Singulair and Artane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Singulair (montelukast sodium) and Artane (trihexyphenidyl hydrochloride). Common drug interactions include cough among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Singulair and Artane. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.

What is Artane?

Artane has active ingredients of trihexyphenidyl hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 3,619 Artane users. Check the latest studies of Artane.



On Jul, 07, 2026

69 people who take Singulair and Artane together, and have interactions are studied.

Singulair and Artane drug interactions.

What are the common drug interactions of Singulair and Artane, by gender? *:

female:

  1. Cough
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  4. Fatigue (feeling of tiredness)
  5. Hepatic steatosis (fatty liver disease)
  6. Hot flush (sudden feelings of heat)
  7. Intervertebral disc degeneration (spinal disc degeneration)
  8. Joint sprain (an injury to joint surrounding flexible fibres)
  9. Lordosis (outward curve of the back bone)
  10. Myalgia (muscle pain)

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Gastroenteritis (inflammation of stomach and intestine)
  3. Abnormal sensation in eye
  4. Hypertriglyceridaemia (excess of triglycerides in the blood)
  5. Affect lability (emotional incontinence)
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Gamma-glutamyltransferase increased
  9. Pyrexia (fever)
  10. Blood alkaline phosphatase increased

What are the common drug interactions of Singulair and Artane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Activities of daily living impaired
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Constipation
  4. Discomfort
  5. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  6. Dysarthria (speech disorder)
  7. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  8. Lethargy (tiredness)
  9. Pain in extremity
  10. Salivary hypersecretion (excess saliva secretion)

10-19:

  1. Nephrolithiasis (calculi in the kidneys)

20-29:

  1. Arthralgia (joint pain)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Drug abuse
  4. Enuresis (repeated inability to control urination)
  5. Gastroenteritis (inflammation of stomach and intestine)
  6. Hypertriglyceridaemia (excess of triglycerides in the blood)
  7. Insomnia (sleeplessness)
  8. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Gastroenteritis (inflammation of stomach and intestine)
  3. Insomnia (sleeplessness)
  4. Enuresis (repeated inability to control urination)
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  6. Renal impairment (severely reduced kidney function)
  7. Arthralgia (joint pain)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Pruritus genital (uneasy irritation of the skin of the vagina and the surrounding area)
  10. Stomatitis (inflammation of mucous membrane of mouth)

40-49:

  1. Cough
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Dyspnoea (difficult or laboured respiration)
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  5. Fatigue (feeling of tiredness)
  6. Hepatic steatosis (fatty liver disease)
  7. Hot flush (sudden feelings of heat)
  8. Hyperglycaemia (high blood sugar)
  9. Intervertebral disc degeneration (spinal disc degeneration)
  10. Joint sprain (an injury to joint surrounding flexible fibres)

50-59:

  1. Affect lability (emotional incontinence)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood lactate dehydrogenase increased
  5. Gamma-glutamyltransferase increased
  6. Pyrexia (fever)
  7. Aggression
  8. Agitation (state of anxiety or nervous excitement)
  9. Blood alkaline phosphatase increased
  10. Blood cholinesterase decreased

60+:

  1. Chronic obstructive airways disease
  2. Ear pain
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cardiac failure congestive
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Cerebrovascular disorder (disease of brain)
  7. Dehydration (dryness resulting from the removal of water)
  8. Dizziness postural
  9. Dysphonia (speech disorder attributable to a disorder of phonation)
  10. Exposed bone in jaw

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 32 people, 46.38%
  2. Hiv Infection: 31 people, 44.93%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 31 people, 44.93%
  4. Dyslipidaemia (abnormal amount of lipids): 31 people, 44.93%
  5. Diabetes: 9 people, 13.04%
  6. Abnormal Sensation In Eye: 8 people, 11.59%
  7. Pain: 4 people, 5.80%
  8. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Singulair and Artane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Singulair and Artane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Artane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Artane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium and trihexyphenidyl hydrochloride (the active ingredients of Singulair and Artane, respectively), and Singulair and Artane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: